Source: Journal of Natural Products. Unidade: FMRP
Subjects: ANTI-INFLAMATÓRIOS (FARMACOLOGIA), INFLAMAÇÃO, INTERLEUCINA 1 (METABOLISMO), PROTEÍNAS QUINASES, ÓXIDO NÍTRICO, LIPOPOLISSACARÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Rangel L. et al. The quassinoid isobrucein B reduces inflammatory hyperalgesia and cytokine production by post-transcriptional modulation. Journal of Natural Products, v. 78, n. 2, p. 241-249, 2015Tradução . . Disponível em: https://doi.org/10.1021/np500796f. Acesso em: 08 nov. 2024.APA
Silva, R. L., Lopes, A. H., França, R. O., Vieira, S. M., Silva, E. C. C., Amorim, R. C. N., et al. (2015). The quassinoid isobrucein B reduces inflammatory hyperalgesia and cytokine production by post-transcriptional modulation. Journal of Natural Products, 78( 2), 241-249. doi:10.1021/np500796fNLM
Silva RL, Lopes AH, França RO, Vieira SM, Silva ECC, Amorim RCN, Cunha F de Q, Pohlit AM, Cunha TM. The quassinoid isobrucein B reduces inflammatory hyperalgesia and cytokine production by post-transcriptional modulation [Internet]. Journal of Natural Products. 2015 ; 78( 2): 241-249.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1021/np500796fVancouver
Silva RL, Lopes AH, França RO, Vieira SM, Silva ECC, Amorim RCN, Cunha F de Q, Pohlit AM, Cunha TM. The quassinoid isobrucein B reduces inflammatory hyperalgesia and cytokine production by post-transcriptional modulation [Internet]. Journal of Natural Products. 2015 ; 78( 2): 241-249.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1021/np500796f
